Vimarsana
Biggest News Aggregation in the World

Page 5 - Biosensor Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosensor Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosensor Platform Today - Breaking & Trending Today

Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX - Vimarsana News

Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX

/PRNewswire/ -- OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global portfolio, is pleased to announce it has acquired a gold...

Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX - Vimarsana News

Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
GBS Inc. Announces Executive Leadership Changes to - Vimarsana News

GBS Inc. Announces Executive Leadership Changes to

NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick - Vimarsana News

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

/PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that...

IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant - ABN Newswire (@ABN_Newswire) - Vimarsana News

IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant - ABN Newswire (@ABN_Newswire)

IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant    Portfolio Company Awarded $6.3M Federal Govt GrantSydney, July 9, 2021 AEST (ABN Newswire) - iQX Limited ( NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, that LSBD's subsidiary GBS today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant to create a pilot Biosensor manufacturing facility. GBS Inc ( NASDAQ:GBS) is a life sciences company developing non-invasive, real-time diagnostic testing for patients...